After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomes

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-12-01
DOI
https://doi.org/10.7326/annals-25-04709-jc
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomes

Eric Bates
Annals of Internal Medicine
Antiplatelet Therapy and Cardiovascular Diseases
article

After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomes

Eric Bates
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(12)
University of Michigan (US)
Openalex Percentile: Top 45%
Antiplatelet Therapy and Cardiovascular Diseases
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomes — Eric Bates · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS